A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life
Clinical trial NCT02354105 · COMPLETED
Trial details
- NCT number
- NCT02354105
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-01-12
- Primary completion
- 2018-03-09
- Enrollment
- 680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.